Suppress rheumatoid inflammation early and leave the pyramid to the Egyptians.

Suppr

超能文献

作者信息

McCarty D J

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.

出版信息

J Rheumatol. 1990 Sep;17(9):1115-8.

PMID:2290150

Abstract

摘要

相似文献

Suppress rheumatoid inflammation early and leave the pyramid to the Egyptians.

J Rheumatol. 1990 Sep;17(9):1115-8.

[Early chronic polyarthritis. Possibilities and limits of inhibition of joint destruction].[早期慢性多关节炎。抑制关节破坏的可能性与局限性]

Internist (Berl). 1993 Apr;34(4):307-15.

Pathophysiology of rheumatoid arthritis: split or lump?类风湿关节炎的病理生理学：分类还是整合？

Arthritis Rheum. 2008 Oct;58(10):2925-7. doi: 10.1002/art.23944.

Reforming the pyramid. A plan for treating rheumatoid arthritis in the 1990s.

Rheum Dis Clin North Am. 1989 Aug;15(3):615-9.

Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone.

J Rheumatol. 1997 Sep;24(9):1849-50.

A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites.一种开发抗炎剂的新方法：炎症部位的腺苷释放。

J Investig Med. 1995 Feb;43(1):50-7.

The clinical evaluation of anti-arthritic drugs.

Int J Clin Pharmacol. 1972 Apr;6(1):40-6.

Rheumatoid arthritis: diagnosis and management.

Clin Symp. 1986;38(2):1-32.

[New treatments in paediatric rheumatology: supportive measures].

Arch Pediatr. 2008 Jun;15(5):870-2. doi: 10.1016/S0929-693X(08)71946-8.

A demonstration of anti-inflammatory effect of indomethacin.消炎痛抗炎作用的演示。

Minn Med. 1967 Jul;50(7):1153-4.

引用本文的文献

[Small molecules and biologicals].[小分子与生物制品]

Z Rheumatol. 2020 Apr;79(3):221-222. doi: 10.1007/s00393-020-00780-9.

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges.类风湿关节炎治疗再评价：策略、机遇与挑战。

Nat Rev Rheumatol. 2015 May;11(5):276-89. doi: 10.1038/nrrheum.2015.8. Epub 2015 Feb 17.

Biomarkers predicting a need for intensive treatment in patients with early arthritis.预测早期关节炎患者强化治疗需求的生物标志物。

Curr Pharm Des. 2015;21(2):170-81. doi: 10.2174/1381612820666140825123104.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.EULAR 推荐的使用合成和生物疾病修饰抗风湿药物治疗类风湿关节炎的建议。

Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5.

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.环孢素A单药治疗与环孢素A联合甲氨蝶呤治疗早期类风湿关节炎患者的疗效比较：一项双盲随机安慰剂对照试验

Ann Rheum Dis. 2003 Apr;62(4):291-6. doi: 10.1136/ard.62.4.291.

Combination therapy for autoimmune diseases: the rheumatoid arthritis model.自身免疫性疾病的联合治疗：类风湿关节炎模型

Springer Semin Immunopathol. 2001;23(1-2):5-26. doi: 10.1007/s002810100063.

Medical management of rheumatoid arthritis.类风湿关节炎的医学管理

BMJ. 1993 Aug 14;307(6901):425-8. doi: 10.1136/bmj.307.6901.425.

Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.类风湿病的临床药理学以及自身免疫和炎症的调节

Drugs. 1994 Feb;47(2):259-85. doi: 10.2165/00003495-199447020-00003.

Methotrexate in rheumatoid arthritis. An update.类风湿关节炎中的甲氨蝶呤。最新进展。

Drugs. 1994 Jan;47(1):25-50. doi: 10.2165/00003495-199447010-00003.

Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.缓慢起效药物：进展缓慢？类风湿关节炎中慢作用抗风湿药物（SAARDs）的应用

Ann Rheum Dis. 1992 Mar;51(3):424-9. doi: 10.1136/ard.51.3.424.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验